tiprankstipranks
Compugen to Release Fourth Quarter and Full Year 2023 Results on Tuesday, March 5, 2024
PremiumPress ReleasesCompugen to Release Fourth Quarter and Full Year 2023 Results on Tuesday, March 5, 2024
2M ago
Is CGEN a Buy, Before Earnings?
PremiumPre-Earnings
Is CGEN a Buy, Before Earnings?
2M ago
Compugen names Michelle Mahler M.D. as Chief Medical Officer
PremiumThe Fly
Compugen names Michelle Mahler M.D. as Chief Medical Officer
2M ago
Compugen spikes 180% on $848M deal with Gilead for anti-tumor drug
PremiumThe FlyCompugen spikes 180% on $848M deal with Gilead for anti-tumor drug
4M ago
Compugen eligible to receive $10M payment upon dosing of AstraZeneca trial
PremiumThe Fly
Compugen eligible to receive $10M payment upon dosing of AstraZeneca trial
4M ago
Gilead and Compugen in license deal for novel pre-clinical immunotherapy program
PremiumThe Fly
Gilead and Compugen in license deal for novel pre-clinical immunotherapy program
4M ago
Truist ‘optimistic’ on Compugen’s approach after Roche data leak
PremiumThe FlyTruist ‘optimistic’ on Compugen’s approach after Roche data leak
8M ago
Compugen reports Q2 EPS (11c), consensus (12c)
PremiumThe Fly
Compugen reports Q2 EPS (11c), consensus (12c)
9M ago
CGEN Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CGEN Upcoming Earnings Report: What to Expect?
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100